USC.edu
Are You a Patient?

Jacob Stephen Thomas, MD

Assistant Professor of Clinical Medicine

Service Chief of LAC+USC Oncology

Image of Jacob Stephen Thomas, MD
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • ERBB2/HER2 landscape and prognostic impact: large-scale, real-world analysis across solid cancers. ESMO Open. 2026 Jul; 11(7):107772.. View in PubMed
  • Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC. Br J Cancer. 2026 Jun; 134(11):1568-1579.. View in PubMed
  • CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study. J Immunother Cancer. 2026 Mar 27; 14(3).. View in PubMed
  • Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium. JCO Oncol Pract. 2025 Dec 04.. View in PubMed
  • Outcomes of Patients With Solid Tumor Treated on Phase I Clinical Trials Within a Comprehensive Cancer Center’s Private and Safety-Net Hospitals. JCO Oncol Pract. 2025 Dec 03.. View in PubMed
  • Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study. EBioMedicine. 2025 Nov; 121:105980.. View in PubMed
  • Impact of Modern Systemic Therapies on Survival in Patients with Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Review. Drugs Real World Outcomes. 2025 Jun; 12(2):295-300.. View in PubMed
  • Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma. Cancer Res Commun. 2025 05 01; 5(5):767-773.. View in PubMed
  • First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors. Clin Cancer Res. 2025 Apr 01; 31(7):1257-1267.. View in PubMed
  • Novel immunotherapy combinations in head and neck squamous cell carcinoma. Curr Opin Oncol. 2025 May 01; 37(3):209-217.. View in PubMed

Similar People